Live from the NIH registry
Studies recruiting near Durham right now
Top 25 of 1,696 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
University of North Carolina at Chapel Hill — Chapel Hill, North Carolina (9.7 mi)
· Sponsor: University of Michigan
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Lineberger Comprehensive Cancer Center — Chapel Hill, North Carolina (9.7 mi)
· Sponsor: American Society of Clinical Oncology
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Duke Cancer Institute (Adults and Pediatrics) — Durham, North Carolina (1.0 mi)
· Sponsor: Pierre Fabre Medicament
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
Generalized Myasthenia Gravis
N/A
Observational 500 participants sought
Clinical Trial Site — Durham, North Carolina (1.0 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Neuromyelitis Optica Spectrum Disorder, NMOSD
N/A
Observational 200 participants sought
Clinical Trial Site — Chapel Hill, North Carolina (9.7 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
Duke Cancer Center — Durham, North Carolina (1.0 mi)
· Sponsor: Revolution Medicines, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Duke University Medical Center — Durham, North Carolina (1.0 mi)
· Sponsor: National Cancer Institute (NCI)
Observation of Environment and Reproductive-Endocrine Effects
Hypogonadism, Hypergonadism
N/A
Observational 300 participants sought
NIEHS Clinical Research Unit (CRU) — Research Triangle Park, North Carolina (6.1 mi)
· Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Cognitive Training and Neuroplasticity in Mild Cognitive Impairment: COGIT-2 Trial
Mild Cognitive Impairment (MCI), Cognitive Training
Phase 2
Interventional 240 participants sought
Duke University Medical Center — Durham, North Carolina (1.0 mi)
· Sponsor: Columbia University
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
Sepsis, Acute Kidney Injury
Phase 2
Interventional 124 participants sought
Research Site — Chapel Hill, North Carolina (9.7 mi)
· Sponsor: AstraZeneca
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
North Carolina Retina Associates — Wake Forest, North Carolina (21.9 mi)
· Sponsor: Boehringer Ingelheim
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
L&E Raleigh — Raleigh, North Carolina (20.6 mi)
· Sponsor: RAI Services Company
Adult and Juvenile Myositis
Dermatomyositis, Polymyositis
N/A
Observational 1,200 participants sought
NIEHS Clinical Research Unit (CRU) — Research Triangle Park, North Carolina (6.1 mi)
· Sponsor: National Institute of Environmental Health Sciences (NIEHS)
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Bladder Carcinoma, Ureter Carcinoma
N/A
Observational 2,285 participants sought
UNC- Chapel Hill — Chapel Hill, North Carolina (9.7 mi)
· Sponsor: Guardant Health, Inc.
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
High Grade Glioma, Diffuse Intrinsic Pontine Glioma
Phase 2
Interventional 120 participants sought
Duke Cancer Center — Durham, North Carolina (1.0 mi)
· Sponsor: Nationwide Children's Hospital
Intervention to Improve Communication and Medication Adherence in Lupus
Systemic Lupus Erythematosus
N/A
Interventional 480 participants sought
Duke University — Durham, North Carolina (1.0 mi)
· Sponsor: Duke University
SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families
Substance Abuse, Intimate Partner Violence (IPV)
N/A
Interventional 400 participants sought
Duke School of Nursing — Durham, North Carolina (1.0 mi)
· Sponsor: Duke University
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Chapel Hill — Chapel Hill, North Carolina (9.7 mi)
· Sponsor: Westat
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Duke Cancer Institute — Durham, North Carolina (1.0 mi)
· Sponsor: Hoffmann-La Roche
HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM
Multiple Myeloma in Relapse, Multiple Myeloma, Refractory
Phase 2
Interventional 27 participants sought
Duke University Health System — Durham, North Carolina (1.0 mi)
· Sponsor: Duke University
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Durham, NC — Durham, North Carolina (1.0 mi)
· Sponsor: Mediar Therapeutics
Pediatrics Mobile CT
Pediatric Abdominal Imaging, Pediatric Imaging
N/A
Interventional 25 participants sought
Duke University Hospital — Durham, North Carolina (1.0 mi)
· Sponsor: Duke University
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
Duke Cancer Institute — Durham, North Carolina (1.0 mi)
· Sponsor: Lyell Immunopharma, Inc.
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Dravet Syndrome
Phase 1, Phase 2
Interventional 32 participants sought
Duke University Health Systems — Durham, North Carolina (1.0 mi)
· Sponsor: Ionis Pharmaceuticals, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Durham VA Medical Center — Durham, North Carolina (1.0 mi)
· Sponsor: SWOG Cancer Research Network